BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31416693)

  • 1. Broad-Range Papillomavirus Transcriptome as a Biomarker of Papillomavirus-Associated Cervical High-Grade Cytology.
    Pérot P; Biton A; Marchetta J; Pourcelot AG; Nazac A; Marret H; Hébert T; Chrétien D; Demazoin MC; Falguières M; Arowas L; Laude H; Heard I; Eloit M
    J Mol Diagn; 2019 Sep; 21(5):768-781. PubMed ID: 31416693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.
    Varga N; Mózes J; Keegan H; White C; Kelly L; Pilkington L; Benczik M; Zsuzsanna S; Sobel G; Koiss R; Babarczi E; Nyíri M; Kovács L; Attila S; Kaltenecker B; Géresi A; Kocsis A; O'Leary J; Martin CM; Jeney C
    Pathol Oncol Res; 2017 Apr; 23(2):295-305. PubMed ID: 27497597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Evaluation of DNA Ploidy for the Triage of HPV-Positive Chinese Women During Cervical Cancer Screening.
    Cang W; Li Q; Gu L; Hong Z; Hu Y; Di W; Qiu L
    Cancer Prev Res (Phila); 2021 Mar; 14(3):355-362. PubMed ID: 33229338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
    Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
    Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.
    Zhao XY; Cui Y; Jiang SF; Liu KJ; Han HQ; Liu XS; Li Y
    Asian Pac J Cancer Prev; 2015; 16(2):693-7. PubMed ID: 25684510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Cervical Lesions and Cancer in Air-Dried Cytologic Smears by Combined Analysis of mRNA and miRNA Expression Levels.
    Ivanov MK; Titov SE; Dzyubenko VV; Glushkov SA; Krasilnikov SE; Mansurova AS; Malek AV; Berlev IV; Prisyazhnaya TS; Kuleshova SV; Hodkevich AA; Lancuhaj YA; Dimitriadi TA; Agletdinov EF
    J Mol Diagn; 2021 May; 23(5):541-554. PubMed ID: 33662584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis of HPV infections].
    Wentzensen N
    Pathologe; 2011 Nov; 32(6):461-6. PubMed ID: 21845360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
    Wang ZM
    Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
    Antonishyn NA; Horsman GB; Kelln RA; Severini A
    Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions?
    Lee KJ; Lee JK; Saw HS
    Arch Pathol Lab Med; 2004 Mar; 128(3):298-302. PubMed ID: 14987159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia.
    Lie AK; Risberg B; Borge B; Sandstad B; Delabie J; Rimala R; Onsrud M; Thoresen S
    Gynecol Oncol; 2005 Jun; 97(3):908-15. PubMed ID: 15943992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
    Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
    [No Abstract]   [Full Text] [Related]  

  • 18. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.